AKT1 and central nervous system cancer: Furthermore, (7) disrupts cell migration, invasion, and PI3K/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) signaling pathway in human glioma cell line (HS-683) and inhibits tumor growth in vivo [43].